Protective effects of Nigella sativa oil, thymoquinone and dexamethasone on bleomycin-induced lung fibrosis in rats

Document Type : Original Article

Authors

1 Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

2 Department of Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Abstract
Pulmonary fibrosis (PF) is a chronic interstitial lung disease with a progressive damage to the air sacs and deposition of collagen fibers in the lung tissue. The study aimed to explore the effects of Nigella sativa oil (NSO) or thymoquinone (TQ), alone or in combination with dexamethasone (DEX), on the development of bleomycin (BLM)-induced PF. Forty-two male rats were divided into seven groups: Control (CTRL); BLM, received a single dose of BLM on day 0, intratracheally; all remaining groups received BLM, as well. DEX, received DEX daily, intraperitoneally, 1 day before BLM and continued for 14 days; NSO and TQ groups, received daily NSO and TQ, respectively, 7 days before BLM and continued for 35 days; DEX + TQ, received both DEX and TQ; DEX + NSO, received both DEX and NSO. At the end, lung tissues were used for histopathological and biochemical analyses. BLM significantly increased the severity of fibrosis and inflammation compared to the CTRL. Bleomycin also significantly increased the amount of hydroxyproline, however, decreased most antioxidant enzymes in the lung tissue compared to the other groups. Group TQ + DEX significantly reduced the severity of BLM-induced PF as well as alterations in biochemical parameters, lung weight and O2 saturation. Nigella sativa oil slightly reduced BLM-induced PF, however, it caused non-significant hyperemia in lung tissue. Thymoquinone potentiated the effects of DEX on most biochemical and pathological alterations of BLM-induced lung injury much better than NSO. More studies are needed to support the use of NSO and TQ as potential protective agents against PF.

Keywords

Subjects


  1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378(9807): 1949-1961.
  2. Kalayarasan S, Sriram N, Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life Sci 2008; 82(23-24): 1142-1153.
  3. Oku H, Shimizu T, Kawabata T, et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 2008; 590(1-3): 400-408.
  4. Uhal BD. Apoptosis in lung fibrosis and repair. Chest 2002; 122(6 Suppl): 293S-298S.
  5. Zargar HR, Hemmati AA, Ghafourian M, et al. Long- term treatment with royal jelly improves bleomycin-induced pulmonary fibrosis in rats. Can J Physiol Pharmacol 2017; 95(1): 23-31.
  6. Boseila AA, Messalam AAH. Immunostimulant effect of different fractions of Nigella sativa L. seeds against Rabies vaccine. Nat Sci 2011; 9(2): 90-96.
  7. Almuhayawi MS. Efficacy of Nigella sativa in wound healing. Indian J Pharm Sci. 2023; 85(S1): 173-181.
  8. Khan MA. Chemical composition and medicinal properties of Nigella sativa Linn. Inflammo-pharmacology 1999; 7(1): 15-35.
  9. Vafaee F, Hosseini M, Hassanzadeh Z, et al. The effects of Nigella sativa hydro-alcoholic extract on memory and brain tissues oxidative damage after repeated seizures in rats. Iran J Pharm Res 2015; 14(2):547-557.
  10. Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, et al. Thymoquinone and its therapeutic potentials. Pharmacol Res 2015; 95-96: 138-158.
  11. Sadeghi E, Imenshahidi M, Hosseinzadeh H. Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review. Mol Biol Rep 2023; 50(60): 5439-5454.
  12. Ahmad A, Alkharfy KM, Jan BL, et al. Thymoquinone treatment modulates the Nrf2/HO-1 signaling pathway and abrogates the inflammatory response in an animal model of lung fibrosis. Exp Lung Res 2020; 46(3-4):53-63.
  13. Houghton PJ, Zarka R, de las Heras B, et al. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica 1995; 61(1): 33-36.
  14. Dik WA, McAnulty RJ, Versnel MA, et al. Short course dexamethasone treatment following injury inhibits bleomycin-induced fibrosis in rats. Thorax 2003; 58(9): 765-771.
  15. Gao W, Tong D, Li Q, et al. Dexamethasone promotes regeneration of crushed inferior alveolar nerve by inhibiting NF-κB activation in adult rats. Arch Oral Biol 2017; 80: 101-109.
  16. Park GY, Christman JW. Involvement of cyclo-oxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 2006; 290(5):L797-L805.
  17. Shi K, Jiang J, Ma T, et al. Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway. Int J Clin Exp Med 2014; 7(9): 2645-2650.
  18. Saghir SAM, Al-Gabri NA, Khafaga AF, et al. Thymo-quinone-PLGA-PVA nanoparticles ameliorate bleomycin-induced pulmonary fibrosis in rats via regulation of inflammatory cytokines and iNOS signaling. Animals (Basel) 2019; 9(11): 951. doi: 10.3390/ani9110951.
  19. Ayala P, Torres J, Vivar R, et al. Changes in the pattern of fibrosis in the rat lung with repetitive orotracheal instillations of gastric contents: evidence of persistent collagen accumulation. Am J Physiol Lung Cell Mol Physiol 2018; 315(3): L390-L403.
  20. Abidi A, Bahri S, Khamsa SB, et al. Nigella sativa fixed oil, attenuates bleomycin-induced pulmonary fibrosis in a rat model. In Proceedings: ERS International Congress abstract. Paris, France 2018; 4796.
  21. El-Khouly D, El-Bakly WM, Awad AS, et al. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats. Toxicology 2012; 302(2-3): 106-113.
  22. Pashangzadeh S, Taherian M, Vafashoar F, et al. The effect of dexamethasone on bleomycin-induced lung fibrosis in the mouse model of systemic sclerosis [Persian]. Qom Univ Med Sci J 2018; 12(8): 86-94.
  23. Khazdair MR, Ghafari S, Sadeghi M. Possible therapeutic effects of Nigella sativa and its thymo-quinone on COVID-19. Pharm Biol 2021; 59(1): 696-703.
  24. Hübner RH, Gitter W, El Mokhtari NE, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 2008; 44(4): 507-517.
  25. Tashiro J, Rubio GA, Limper AH, et al. Exploring animal models that resemble idiopathic pulmonary fibrosis. Front Med (Lausanne) 2017; 4: 118. doi: 10.3389/ fmed.2017.00118.
  26. Della Latta V, Cecchettini A, Del Ry S, et al. Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res 2015; 97: 122-130.
  27. Li L, Li Q, Wei L, et al. Dexamethasone combined with berberine is an effective therapy for bleomycin‑ induced pulmonary fibrosis in rats. Exp Ther Med 2019; 18(4): 2385-2392.
  28. Kalemci S, Zeybek A, Kargi AB. Can the development of lung fibrosis be prevented after COVID-19 infection? Kardiochir Torakochirurgia Pol 2022; 19(2): 113. doi: 10.5114/kitp.2022.117505.
  29. Javadi I, Rashidi Nooshabadi M, Goudarzi M, et al. Protective effects of celery (Apium graveloens) seed extract on bleomycin-induced pulmonary fibrosis in rats. J Babol Univ Med Sci 2015; 17(1): 70-76.
  30. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999; 424(1-2): 83-95.
  31. Amani S, Noorbakhsh MF, Ahmadi N, et al. Evaluation of the protective effect of citral, silymarin, and thymoquinone on methotrexate-induced lung injury in rats. J Pharmacopuncture 2023; 26(2): 184-191.
  32. Erboga M, Erboga ZF, Donmez YB, et al. Nigella sativa attenuates bleomycin-induced pulmonary fibrosis in rats by inhibition of inflammation, fibrosis, and inducible nitric oxide synthase. J Exp Clin Med 2015; 32(3): 121-125.
  33. Alzohairy MA, Khan AA, Alsahli MA, et al. Protective effects of thymoquinone, an active compound of Nigella sativa, on rats with Benzo(a)pyrene-induced lung injury through regulation of oxidative stress and inflammation. Molecules 2021; 26(11): 3218. doi: 10.3390/molecules26113218.
  34. Moeller A, Rodriguez-Lecompte JC, Wang L, et al. Models of pulmonary fibrosis. Drug Discov Today Dis Models 2006; 3(3): 243-249.
  35. Samareh-Fekri M, Poursalehi HR, Mandegary A, et al. The effect of methanol extract of fennel on bleomycin-induced pulmonary fibrosis in rats [Persian]. J Kerman Univ Med Sci 2015; 22(6): 470-483.
  36. Boskabady M, Khazdair MR, Bargi R, et al. Thymoquinone ameliorates lung inflammation and pathological changes observed in lipopolysaccharide-induced lung injury. Evid Based Complement Alternat Med 2021; 2021: 6681729. doi: 10.1155/2021/ 6681729.
  37. Li HP, Li X, He GJ, et al. The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin‐induced pulmonary fibrosis in rats. Respirology 2004; 9(1): 25-32.
Volume 15, Issue 11
November 2024
Pages 613-620

  • Receive Date 03 April 2024
  • Revise Date 26 June 2024
  • Accept Date 17 July 2024